Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

8.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

2.6K
2.6K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

5.9K
5.9K
Cancer Survival Analysis01:21

Cancer Survival Analysis

862
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
862

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Engineering Nanoemulsions to Maximize NIR-II Fluorescence and Preserve Photothermal Performance of a Novel Boron Difluoride Formazanate Dye.

Angewandte Chemie (International ed. in English)·2026
Same author

Integrating In-vitro Permeability Assays within PBPK Modeling to Predict CNS Distribution of Standard and Engineered Antibodies.

The AAPS journal·2026
Same author

Multifunctional ACE2-nanobody fusion design for pan-specific neutralization and cardiovascular protection in SARS coronavirus infection.

Antimicrobial agents and chemotherapy·2026
Same author

Co-encapsulation of temozolomide and PbS quantum dots in apoferritin for transferrin receptor 1 targeting, imaging and treatment of glioblastoma.

Nanoscale advances·2025
Same author

Synthesis of α,ε-<i>N</i>,<i>N</i>'-Di-stearoyl Lysine-Derived Amide Lipids and Their Application to Liposome Formulation: Incorporation of Lipid A-Ligand for Bacterial Targeting and Sialic Acid for Phagocytosis Resistance.

International journal of molecular sciences·2025
Same author

Use of Coiled-Coil Affinity Peptides to Manufacture Antibody Conjugates.

Bioconjugate chemistry·2025

Related Experiment Video

Updated: Apr 30, 2026

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
08:00

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

Published on: October 11, 2019

9.1K

Gene expression correlation for cancer diagnosis: a pilot study.

Binbing Ling1, Lifeng Chen1, Qiang Liu2

  • 1Drug Discovery and Development Research Group, College of Pharmacy and Nutrition, University of Saskatchewan, 107 Wiggins Road, Saskatoon, SK, Canada S7N 5E5.

Biomed Research International
|May 13, 2014
PubMed
Summary

Gene expression correlations may indicate early cancer development. This study found strong correlations between PIK3C3, PIM3, and PTEN genes in various cancers, suggesting their potential as diagnostic biomarkers.

More Related Videos

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

974
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.6K

Related Experiment Videos

Last Updated: Apr 30, 2026

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
08:00

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

Published on: October 11, 2019

9.1K
Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

974
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.6K

Area of Science:

  • Oncology
  • Genomics
  • Biomolecular Networks

Background:

  • Late-stage cancers have poor prognoses, driving the search for early detection biomarkers.
  • Biomolecular network analysis offers a novel strategy for detecting tumorigenesis and metastasis.
  • Distinct biomolecular networks in normal versus cancerous states suggest potential diagnostic indicators.

Purpose of the Study:

  • To investigate if mRNA expression correlations of PIK3C3, PIM3, and PTEN genes can indicate early cancer development.
  • To determine if correlation coefficients of these genes can be utilized for cancer diagnosis.
  • To explore the utility of gene expression correlations as supplementary cancer biomarkers.

Main Methods:

  • Examined mRNA expressions of PIK3C3, PIM3, and PTEN genes.
  • Analyzed gene expression correlations during cancer progression across multiple cancer types.
  • Calculated correlation coefficients to assess diagnostic potential.

Main Results:

  • Observed strong correlations (0.68 ≤ r ≤ 1.0) between PIK3C3 and PIM3 in breast cancer.
  • Found strong correlations between PIK3C3 and PTEN in breast and ovary cancers.
  • Detected strong correlations between PIM3 and PTEN in breast, kidney, liver, and thyroid cancers.

Conclusions:

  • Correlations in cancer network gene expressions show promise as early cancer diagnostic indicators.
  • These gene expression correlations could supplement existing clinical biomarkers like cancer antigens.
  • The findings support the hypothesis that gene expression correlations are valid indicators of early cancer development.